Clinical Trials Browser

Completed × Diphosphonates × Plasma cell × Clear all

NCT01215344 2018-05-15

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade

Phase 2 Completed

36 enrolled 8 charts

Multiple Myeloma